※ Cumulative through Sep 22, 2026, vs. same period last year
PHIL INTER PHARMA USA, INC. shipped 63 cases to Korea in 2026, up 3% from the same period last year (61 cases). Main origins: United States of America.
Top exported products: DEEP SEA PHOSPHATIDYLSERINE GINKGO PLUS 3 cases (up 200%), THE FINE GINKGO MAG SINSIA 3 cases (no same-period record last year · last Mar 2026, 3 cases total), POST GREEN RTG OMEGA3 PREMIUM 2 cases (unchanged).
Top importers: Cosmo Pharm Co., Ltd. 12 cases (up 71%), Dongsin Healthcare Co., Ltd. 9 cases (up 80%), Medi ESI 6 cases (down 14%).
Top trading importer: Cosmo Pharm Co., Ltd. accounts for 19.0% of all recorded cases in the stated period.
| Product | Shipments | vs. last year |
|---|---|---|
| DEEP SEA PHOSPHATIDYLSERINE GINKGO PLUS | 3 | ▲ +200% |
| THE FINE GINKGO MAG SINSIA | 3 | New |
| POST GREEN RTG OMEGA3 PREMIUM | 2 | Unchanged |
| BRAIN 1088 | 2 | ▲ +100% |
| HAPPY LADY | 2 | ▲ +100% |
| Importer | Shipments | vs. last year |
|---|---|---|
| Cosmo Pharm Co., Ltd. | 12 | ▲ +71% |
| Dongsin Healthcare Co., Ltd. | 9 | ▲ +80% |
| Medi ESI | 6 | ▼ -14% |
| Welriseuon Co., Ltd. | 6 | ▲ +20% |
| JB Pamiseu (JB Pharmis Co., Ltd.) Co., Ltd. | 5 | ▲ +25% |
| Country | Shipments | vs. last year |
|---|---|---|
| United States of America | 63 | — |
Source: Ministry of Food and Drug Safety import records, compiled by TAAMs. Current period: 2026-05-01 ~ 2026-09-22; prior-year comparison: 2025-05-01 ~ 2025-09-22. Counts are source-record rows, not transaction value or contract counts.